Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Big pharma’s key catalysts in the second quarter
EP Vantage
Wed, 03/24/21 - 10:04 am
Tags:
Biogen, Alzheimer's disease, aducanumab, Sanofi, breast cancer, FDA
Fidia Farmaceutici acquires Sanofi’s anti-inflammatory drugs portfolio
Pharmaceutical Business Review
Wed, 03/24/21 - 10:00 am
Tags:
Sanofi, Fidia Farmaceutici, M&A, anti-inflammatories
With all the buzz in gene therapy, Sanofi offloads two small molecule sickle cell programs from $11.6B buyout to Global Blood Therapeutics
Endpoints
Tue, 03/16/21 - 10:55 am
Tags:
Sanofi, sickle cell disease, gene therapy, gene editing, Global Blood Therapeutics
GSK kick-starts phase 3 Medicago-partnered COVID vaccine test
Fierce Biotech
Tue, 03/16/21 - 10:52 am
Tags:
GSK, Sanofi, UK, Medicago, vaccines, COVID-19
Sanofi, Regeneron’s Libtayo improves survival in cervical cancer patients
Pharma Times
Mon, 03/15/21 - 10:48 am
Tags:
Sanofi, Regeneron, Libtayo, cervical cancer, clinical trials
Sanofi/Translate start clinical trial of mRNA COVID shot
Pharmaforum
Fri, 03/12/21 - 10:31 am
Tags:
Sanofi, Translate Bio, vaccines, COVID-19, clinical trials, MRNA
A year into Sanofi's revamp, CEO Paul Hudson collects €11.34M in 2020 pay—including that signing bonus
Fierce Pharma
Fri, 03/5/21 - 10:48 am
Tags:
Sanofi, Paul Hudson, Pharma CEOs, executive pay
A busy year ahead for Parkinson’s disease
EP Vantage
Wed, 03/3/21 - 10:56 am
Tags:
Parkinson's Disease, drug development, AstraZeneca, Roche, Prothena, MeiraGTx, Annovis Bio, Sanofi, Alkahest, Peptron, SAGE Therapeutics
While Life Sciences Industry Remains Strong, Some Big Names Face Layoffs
BioSpace
Tue, 03/2/21 - 12:15 pm
Tags:
COVID-19, pandemic, layoffs, Gilead Sciences, Amgen, GSK, Sanofi, Viatris
Sanofi and GSK target Q4 2021 for COVID-19 vaccine rollout
Biopharma Reporter
Tue, 02/23/21 - 10:48 am
Tags:
Sanofi, GSK, COVID-19, vaccines
After setback, Sanofi, GSK take tweaked COVID-19 vaccine into phase 2
Fierce Biotech
Mon, 02/22/21 - 10:43 am
Tags:
Sanofi, GSK, clinical trials, COVID-19, vaccines
After Pfizer deal, Sanofi offers a hand to Johnson & Johnson for COVID-19 vaccine production
Fierce Pharma
Mon, 02/22/21 - 10:38 am
Tags:
Sanofi, vaccines, COVID-19, JNJ, Pfizer
Sanofi invests in health tech firm Novadiscovery, boosting trial simulation platform and COVID-19 work
Fierce Biotech
Wed, 02/17/21 - 10:50 am
Tags:
Sanofi, clinical trial simulation, COVID-19, Novadiscovery, JINKO
Bristol-Myers, Sanofi ordered to pay Hawaii $834 million over Plavix warning label
Reuters
Tue, 02/16/21 - 11:07 am
Tags:
Bristol-Myers Squibb, Sanofi, Plavix, Hawaii, deceptive marketing, labeling
Sanofi’s COVID-19 Vaccine With Translate Bio Delayed Until Next Year – Report
Yahoo/SmarterAnalyst
Sun, 02/14/21 - 09:20 pm
Tags:
Sanofi, Translate Bio, COVID-19, vaccines
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Endpoints
Fri, 02/12/21 - 10:48 am
Tags:
Amgen, patents, Sanofi, Regeneron, Praluent, Repatha, Merck
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
Yahoo/Benzinga
Wed, 02/10/21 - 10:32 am
Tags:
Sanofi, Regeneron, Libtayo, FDA, advanced basal cell carcinoma, skin cancer
Pharma Sanofi CEO: mRNA is likely the 'go-to' vaccine tech for a pandemic, but the 'bar is high' in other diseases
Fierce Pharma
Tue, 02/9/21 - 12:49 pm
Tags:
Sanofi, Pharma CEO, MRNA, vaccines, COVID-19
Sanofi revises fitusiran dosing to cut risk of thrombotic events in hemophilia phase 3
Fierce Biotech
Mon, 02/8/21 - 10:41 am
Tags:
Sanofi, fitusiran, hemophilia, hemophilia A, hemophila B
Regeneron has a winner in Dupixent and big sales hopes. So why are so few patients taking it?
Endpoints
Mon, 02/8/21 - 10:25 am
Tags:
Dupixent, Regeneron, Sanofi, eczema

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.